Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays

Transfusion

Volumn 36, Issue 5, 1996, Pages 401-405

  Allain, J P ^a   Kitchen, A ^b   Aloysius, S ^c   Reeves, I ^d   Petrik, J ^a   Barbara, J A J ^c   Williamson, L M ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Brentwood Transfusion Centre   (United Kingdom)

^c North London Blood Transfusion Centre   (United Kingdom)

^d East Anglian Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; RISK ASSESSMENT; SCREENING TEST; VIRUS DIAGNOSIS;

EID: 0029885304     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36596338024.x     Document Type: Article

References (23)

1. Goodrick MJ, Gray SF, Rouse AM, et al. Hepatitis C (HCV)-positive blood donors in south-west England: a case control study. Transfus Med 1994;4:113-9.
2. Crawford RJ, Gillon J, Yap PL, et al. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med 1994;4:121-4.
3. Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med 1987;317:238-41.
4. Schwartz JS, Dans PE, Kinosian BP. Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better. JAMA 1988;259:2574-9.
5. Wagstaff W, ed. UK National Guidelines for confirmation and donor handling. London: HMSO Publication Centre, 1993.
6. Petrik J, Allain JP, Pearson G, inventors; University of Cambridge, Cambridge, UK, assignee. Oligonucleotides and their use. United Kingdom. British patent specification application No. 9415129.7; Appl. 1994 July 27.
7. Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991;14:51-5.
8. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
9. Teo CG, Gabriel FG, Mortimer PP. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation. J Clin Pathol 1992;45:917-20.
10. Wartick MG, McCarroll DR, Wiltbank TB. A second discriminator for biological false positive results in enzyme-linked immunosorbent assays for antibodies to human immunodeficiency virus (HTLV-III/LAV). Transfusion 1987;27:109-11.
11. Gabriel FG, Teo CG. Peptide based enzyme immunoassays for detecting hepatitis C antibodies in sera of people at high risk. J Clin Pathol 1994;47:357-9.
12. Gray JJ, Geraghty B, Desselberger U. Algorithms for hepatitis C virus antibody testing of samples collected from high risk populations. PHLS Microbiol Digest 1994;10:182-7.
13. Das PC, Heethuis A, McShine RL, Sibinga CT. Supplemental HCV antibody assay in blood donors by RIBA and line immunoassay (letter). Transfus Med 1994;4:173-5.
14. Zaaijer HL, Cuypers HT, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-4.
15. Leon P, Lopez JA, Domingo CJ, et al. Serological studies and hepatitis C virus RNA in serum samples from blood donors with indeterminate results in second-generation recombinant immunoblot assay (letter). Vox Sang 1994;66:245-6.
16. Jha J, Arankalle VA, Banerjee K. Hepatitis C virus RNA positivity among RIBA-3 indeterminates (letter). Vox Sang 1995;69:145-6.
17. Zanella A, Conte D, Prati D, et al. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 1995;21:913-7.
18. Serfaty L, Giral P, Elghouzzi MH, et al. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology 1993;17:183-7.
19. Buffet C, Charnaux N, Laurent-Puig P, et al. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay. J Med Virol 1994;43:259-61.
20. Mutimer DJ, Harrison RF, O'Donnell KB, et al. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity. BMJ 1994;309:847-8.
21. Sugitani M, Inchauspé G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992;339:1018-9.
22. Blajchman MA, Bull SB, Feinman SV. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 1995;345:21-5.
23. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 1995;68:55-6.